Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Klaus A. Dugi | Researchclopedia

Back to researchers

Klaus A. Dugi

95

Works

5,558

Citations

43

h-index

67

i10-index

Research Topics

Diabetes Treatment and Management Pancreatic function and diabetes Lipid metabolism and disorders

Affiliations

Henry M. Jackson Foundation1996–1996

National Institutes of Health1994–1999

Boehringer Ingelheim (Germany)2007–2016

Philipps University of Marburg1991–2001

Cornell University2000–2000

Top Works

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Baptist Gallwitz,Julio Rosenstock,et al.

2012336 citations

Diabetes, Cardiovascular Risks, and Lipoproteins

Metabolism, Diabetes, and Cancer

Effect of linagliptin monotherapy on glycaemic control and markers of <i>β</i> ‐cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial

Stefano Del Prato,Anthony Barnett,et al.

2010298 citations

Safety and efficacy of linagliptin as add‐on therapy to metformin in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled study

Marja‐Riitta Taskinen,Julio Rosenstock,et al.

2010293 citations

Die Gutenberg Gesundheitsstudie

Philipp S. Wild,Tanja Zeller,et al.

2012236 citations

Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24‐week randomized study<sup>1</sup>

D. R. Owens,Ros Swallow,et al.

2011213 citations

Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double‐blind, placebo‐controlled study

Ramón Gomis,Rosa-Maria Espadero,et al.

2011177 citations

Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase‐4 inhibitor in male type 2 diabetes patients

Tim Heise,Eva U. Graefe-Mody,et al.

2009175 citations

Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease

Maximilian von Eynatten,Philipp M. Lepper,et al.

2007171 citations

Activation of Tubular Epithelial Cells in Diabetic Nephropathy

Michael Morcos,Ahmed Sayed,et al.

2002157 citations